MYCOPHENOLATE

mycophenolate mofetil 500 mg tablet, 50
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 300 # of repeats: 5 DPMQ: $138.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
ARX-MYCOPHENOLATE
Ceptolate
Mycophenolate GH
Mycophenolate Sandoz
Pharmacor Mycophenolate 500
mycophenolate mofetil 500 mg tablet, 50
Manner of administration:Oral
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9691)

Indication: Management of renal allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 9693)

Indication: Management of cardiac allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 300 # of repeats: 5 DPMQ: $128.58 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
ARX-MYCOPHENOLATE
Ceptolate
Mycophenolate GH
Mycophenolate Sandoz
Pharmacor Mycophenolate 500
mycophenolate mofetil 500 mg tablet, 50
Manner of administration:Oral
General Schedule
No restrictions
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 3 Max qty units: 150 # of repeats: 5 DPMQ: $75.66 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
ARX-MYCOPHENOLATE
Ceptolate
Mycophenolate GH
Mycophenolate Sandoz
Pharmacor Mycophenolate 500
mycophenolate mofetil 500 mg tablet, 50
Manner of administration:Oral
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 5795)

Indication: Management of renal allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 5554)

Indication: Management of cardiac allograft rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 300 # of repeats: 5 DPMQ: $115.08 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
ARX-MYCOPHENOLATE
Ceptolate
Mycophenolate GH
Mycophenolate Sandoz
Pharmacor Mycophenolate 500